Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial. Am Heart J. 2018 03; 197:1-8.